WHO Raises Concern Over Acute Lack of Weight-Loss Medications

Under one in 10 patients who could benefit from weight-loss injections including Wegovy are able to get them, caution the World Health Organization as it releases its initial recommendations on the therapies.

Considering in excess of 1,000,000,000 people worldwide now classified as obese, it is advocating for increased and just availability to these injectable treatments.

Based on estimates, more than two billion could be living with obesity by 2030 without intervention.

"The latest guidance affirms that excess weight is a chronic disease that can be addressed with comprehensive and continuous treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are key barriers to universal access to the treatments that can help people shift considerable body mass, says the organization.

Weight-Loss Drug Supply Crisis

Even under the current most optimistic outlook, the production of such drugs could only cover about 100 million people – fewer than 10% of the global need, according to the WHO.

The advice calls on nations and manufacturers to expand access, through strategies like patent sharing.

The intellectual property rights on the active ingredient – the primary ingredient of the drug Wegovy – is scheduled to end in a number of nations in 2026.

How Weight-Loss Injections Operate

These medications imitate a body's own hormone to reduce digestion speed, suppress the appetite and increase satiety so people consume fewer calories.

Patients typically start to lose weight after several weeks of commencing the once-weekly jabs.

Evidence points to users may put most of the weight back on within a year of halting the treatment, because their normal food cravings return.

To be overweight or obese raises your chance for developing diseases, like diabetes, heart disease, stroke, and some malignancies.

Excess weight concerns individuals in all nations and was associated with 3.7 million fatalities worldwide in 2024, as per the WHO.